Angielski
The most powerful psychological weapon ever created has been unleashed.
It's a weapon the government is willing to kill for.
A weapon Big Pharma refuses to acknowledge.
A weapon that's only a prescription away.
It's been six months since the release of Asteria Pharmaceutical's groundbreaking sleeping pill, and already, profits are soaring. With the original clinical trial outliers in hiding and on the run, Asteria CEO George Sturgis has had free rein to disperse his revolutionary gene-altering medication to the masses, with little regard for Ocula's unconventional side effects.
Meanwhile, in Langley, the Director of Central Intelligence has taken notice of Ocula's success and is determined to take the drug off the streets-even if it means rebooting a dangerous project she swore she would eliminate for good.
As the original outliers get pulled deeper into the Ocula conspiracy, they'll soon discover that they're not the only ones dreaming.
----------------------
Clinical trials for the world's first gene-altering sleeping pill lead to extraordinary side effects in the long-awaited sequel to 2016's The R.E.M. Effect.
Dive into a fast-paced techno-thriller that explores Big Pharma corruption, clandestine government experiments, and the mysteries of the mind to create a world where taking a pill could mean taking lives.
And if you like this book, don't miss the third and final installment in the REM trilogy, The R.E.M. Precept, out now!
Near Future Science Fiction Thrillers by J.M. Lanham
THE R.E.M. EFFECT (The REM Series, Book 1)
THE R.E.M. PROJECT (The REM Series, Book 2)
THE R.E.M. PRECEPT (The REM Series, Book 3)
The R.E.M. Series contains adult language and a handful of violent scenarios, and is intended for mature audiences.
